ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryDietlikonStallergenes AG
Stallergenes AG Logo
Verified· 4 sourcesTrust Score
Summary

About the company

The core activity of Stallergenes Greer is the manufacture of allergen extracts for allergy immunotherapy (AIT) and the provision of solutions for allergy management, including diagnosis, treatment and prevention of allergies.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Stallergenes AG

✓ Offered6
Allergen immunotherapy (AIT)
Allergen immunotherapy for respiratory and food allergies, as sublingual tablets and solutions, subcutaneous injections and oral powder therapy.
Allergy diagnostics
Diagnosis of respiratory and food allergies with medical history, physical examination, skin prick tests, blood tests and oral food challenges.
PALFORZIA®
PALFORZIA® for the treatment of a peanut allergy, with patient information and accompanying Educational Risk Minimisation Materials.
Dust-mite-proof bedding (Encasings)
Dust-mite-proof bedding and covers for house dust mite allergy, available via the online shop.
Allergen production
Manufacture of allergen extracts and approved finished medicinal products, as well as personalised individual formulations and named patient products.
Clinical development
Clinical studies and real-world studies of allergen immunotherapies for early bloomers, sweet grasses, house dust mites and peanuts.
Trust & reputation

ranQ Trust Score of Stallergenes AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 100% · As of October 2026

Stallergenes AG scores 63.5 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.73.124%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.35.310%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.70.08%
Stallergenes AG scores 92.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Stallergenes AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Stallergenes AG scores 38.6 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.77.14%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.0.04%
Qualifications+0.00

Stallergenes AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». The rating draws, among other things, on 5.0 out of 5 stars from 3 customer reviews. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
5
of 5

Aggregated from 3 reviews across all connected sources

Sources
GGoogle53
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

July 1, 2026Media
Deloitte zeichnet drei Unternehmen neu aus
punkt4.info

Knowledge

No knowledge articles yet

Once Stallergenes AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Stallergenes AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Stallergenes AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Stallergenes AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Aegertstrasse 11
8305 Dietlikon
Opening hours
Mon
08:30 - 12:30, 13:30 - 17:00
Tue
08:30 - 12:30, 13:30 - 17:00
Wed
08:30 - 12:30, 13:30 - 17:00
Thu
08:30 - 12:30, 13:30 - 17:00
Fri
08:30 - 12:30, 13:30 - 16:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-108.533.507
Founded
1996 · 30 years
Last commercial register change
July 9, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AA
    ALK-Abelló AG
    Wallisellen
    MT
    Memo Therapeutics AG
    Schlieren
    CA
    CUTISS AG
    Schlieren
    BT
    BEO Therapeutics AG
    Zurich
    DT
    Denali Therapeutics CH GmbH
    Zurich
    FH
    Future Health Pharma GmbH
    Wetzikon Zh 1
    OP
    Otsuka Pharmaceutical (Switzerland) GmbH
    Glattbrugg
    SB
    Swiss Bioscience GmbH
    Schlieren